中天生物科技的MS-20 (Daidezin, Genistein) 檢送中國醫藥大學附設醫院的廖光福醫師主持MS-20口服液劑，獲得衛生署同意進行第二期人體試驗，採用指標為[改善末期肝癌生活品質]
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.